Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer.

Yang, Xiaobing; Zhao, Jiahui; Wei, Dechao; Feng, Tao; Guo, Pengju; Li, Qiankun; Wang, Yongxing; Han, Yili; Li, Mingchuan; Jiang, Yongguang; Luo, Yong

Yang, Xiaobing; Zhao, Jiahui; Wei, Dechao; Feng, Tao; Guo, Pengju; Li, Qiankun; Wang, Yongxing; Han, Yili; Li, Mingchuan; Jiang, Yongguang; Luo, Yong.

Afiliación

Yang X; Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhao J; Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Wei D; Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Feng T; Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Guo P; Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li Q; Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Wang Y; Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Han Y; Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li M; Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jiang Y; Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Luo Y; Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

J Chemother ; 35(8): 760-770, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37011019

Asunto(s)

Neoplasias de la Próstata Resistentes a la Castración; Masculino; Humanos; Neoplasias de la Próstata Resistentes a la Castración/tratamiento farmacológico; Neoplasias de la Próstata Resistentes a la Castración/metabolismo; Neoplasias de la Próstata Resistentes a la Castración/patología; Trióxido de Arsénico/farmacología; Trióxido de Arsénico/uso terapéutico; Receptores Androgénicos/genética; Receptores Androgénicos/metabolismo; Receptores Androgénicos/uso terapéutico; Resistencia a Antineoplásicos; Línea Celular Tumoral; Nitrilos/farmacología; Proliferación Celular

Palabras clave

Arsenic trioxide; DNA damage repair; Enzalutamide; castration-resistant prostate cancer; combination therapy; drug resistance

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Límite: Humans / Male Idioma: En Revista: J Chemother Asunto de la revista: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google